{"id":"https://openalex.org/W1978804432","doi":"https://doi.org/10.1016/s0168-8278(09)60650-4","title":"648 DIFFERENCES IN ANTIVIRAL ACTIVITY AND TOLERABILITY BETWEEN PEGYLATED INTERFERON ALPHA \u2013 2A AND \u2013 2B IN HIV INFECTED PATIENTS WITH CHRONIC HEPATITIS C","display_name":"648 DIFFERENCES IN ANTIVIRAL ACTIVITY AND TOLERABILITY BETWEEN PEGYLATED INTERFERON ALPHA \u2013 2A AND \u2013 2B IN HIV INFECTED PATIENTS WITH CHRONIC HEPATITIS C","publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W1978804432","doi":"https://doi.org/10.1016/s0168-8278(09)60650-4","mag":"1978804432"},"language":"en","primary_location":{"id":"doi:10.1016/s0168-8278(09)60650-4","doi":"https://doi.org/10.1016/s0168-8278(09)60650-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0168-8278(09)60650-4","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073032472","display_name":"Eugenia Vispo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122586","display_name":"SciClone Pharmaceuticals (United States)","ror":"https://ror.org/02yfrka70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Vispo","raw_affiliation_strings":["Roche, Nutley, NJ, USA;","SciClone Pharmaceuticals, Inc., Foster City,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ, USA;","institution_ids":[]},{"raw_affiliation_string":"SciClone Pharmaceuticals, Inc., Foster City,","institution_ids":["https://openalex.org/I4210122586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045875110","display_name":"Paula Tuma","orcid":"https://orcid.org/0000-0001-8734-4815","observed_orcids":["https://orcid.org/0000-0001-8734-4815"]},"institutions":[{"id":"https://openalex.org/I4210122586","display_name":"SciClone Pharmaceuticals (United States)","ror":"https://ror.org/02yfrka70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Tuma","raw_affiliation_strings":["Roche, Nutley, NJ, USA;","SciClone Pharmaceuticals, Inc., Foster City,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ, USA;","institution_ids":[]},{"raw_affiliation_string":"SciClone Pharmaceuticals, Inc., Foster City,","institution_ids":["https://openalex.org/I4210122586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009682975","display_name":"J. Medra\u00f1o","orcid":"https://orcid.org/0000-0003-2604-3589","observed_orcids":["https://orcid.org/0000-0003-2604-3589"]},"institutions":[{"id":"https://openalex.org/I4210122586","display_name":"SciClone Pharmaceuticals (United States)","ror":"https://ror.org/02yfrka70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Medrano","raw_affiliation_strings":["Roche, Nutley, NJ, USA;","SciClone Pharmaceuticals, Inc., Foster City,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ, USA;","institution_ids":[]},{"raw_affiliation_string":"SciClone Pharmaceuticals, Inc., Foster City,","institution_ids":["https://openalex.org/I4210122586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003553956","display_name":"Pablo Barreiro","orcid":"https://orcid.org/0000-0002-3819-5371","observed_orcids":["https://orcid.org/0000-0002-3819-5371","https://orcid.org/0000-0001-9062-8835"]},"institutions":[{"id":"https://openalex.org/I4210122586","display_name":"SciClone Pharmaceuticals (United States)","ror":"https://ror.org/02yfrka70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Barreiro","raw_affiliation_strings":["Roche, Nutley, NJ, USA;","SciClone Pharmaceuticals, Inc., Foster City,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ, USA;","institution_ids":[]},{"raw_affiliation_string":"SciClone Pharmaceuticals, Inc., Foster City,","institution_ids":["https://openalex.org/I4210122586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066159389","display_name":"Sonia Rodr\u00edguez\u2010N\u00f3voa","orcid":"https://orcid.org/0000-0003-4225-3631","observed_orcids":["https://orcid.org/0000-0003-4225-3631"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4405267304","display_name":"Veristat, LLC (United States)","ror":"https://ror.org/023qnpq80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267304"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"S. Rodriguez-Novoa","raw_affiliation_strings":["Roche, Basel, Switzerland","Versante International, Inc., Piedmont, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Versante International, Inc., Piedmont, CA,","institution_ids":["https://openalex.org/I4405267304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016018012","display_name":"Judit Morell\u00f3","orcid":"https://orcid.org/0000-0002-1148-9329","observed_orcids":["https://orcid.org/0000-0002-1148-9329"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4405267304","display_name":"Veristat, LLC (United States)","ror":"https://ror.org/023qnpq80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267304"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"J. Morello","raw_affiliation_strings":["Roche, Basel, Switzerland","Versante International, Inc., Piedmont, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Versante International, Inc., Piedmont, CA,","institution_ids":["https://openalex.org/I4405267304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072006119","display_name":"Pablo Labarga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122586","display_name":"SciClone Pharmaceuticals (United States)","ror":"https://ror.org/02yfrka70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Labarga","raw_affiliation_strings":["Roche, Nutley, NJ, USA;","SciClone Pharmaceuticals, Inc., Foster City,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ, USA;","institution_ids":[]},{"raw_affiliation_string":"SciClone Pharmaceuticals, Inc., Foster City,","institution_ids":["https://openalex.org/I4210122586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060981735","display_name":"Luz Mart\u00edn\u2010Carbonero","orcid":"https://orcid.org/0000-0001-8102-4079","observed_orcids":["https://orcid.org/0000-0001-8102-4079"]},"institutions":[{"id":"https://openalex.org/I4210122586","display_name":"SciClone Pharmaceuticals (United States)","ror":"https://ror.org/02yfrka70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122586"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"L. Martin-Carbonero","raw_affiliation_strings":["Roche, Nutley, NJ, USA;","SciClone Pharmaceuticals, Inc., Foster City,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ, USA;","institution_ids":[]},{"raw_affiliation_string":"SciClone Pharmaceuticals, Inc., Foster City,","institution_ids":["https://openalex.org/I4210122586"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009751300","display_name":"Vincent Soriano","orcid":"https://orcid.org/0000-0002-4624-5199","observed_orcids":["https://orcid.org/0000-0002-4624-5199"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4405267304","display_name":"Veristat, LLC (United States)","ror":"https://ror.org/023qnpq80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267304"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"V. Soriano","raw_affiliation_strings":["Roche, Basel, Switzerland","Versante International, Inc., Piedmont, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Versante International, Inc., Piedmont, CA,","institution_ids":["https://openalex.org/I4405267304"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060981735"],"corresponding_institution_ids":["https://openalex.org/I4210122586"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4275,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.7038105,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"50","issue":null,"first_page":"S238","last_page":"S239"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peginterferon-alfa-2a","display_name":"peginterferon alfa-2a","score":0.9580000042915344},{"id":"https://openalex.org/keywords/peginterferon-alfa-2b","display_name":"peginterferon alfa-2b","score":0.9620000123977661},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hiv-coinfection","display_name":"HIV coinfection","score":0.7839999794960022},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.8519999980926514},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7879999876022339},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pulmonary-toxicity","display_name":"pulmonary toxicity","score":0.5809999704360962},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.8199999928474426},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.47600001096725464},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.6010000109672546},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.4169999957084656},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.5339999794960022},{"id":"https://openalex.org/keywords/europe","display_name":"Europe","score":0.3319999873638153},{"id":"https://openalex.org/keywords/us-japan-comparison","display_name":"Japan-US comparison","score":0.36800000071525574},{"id":"https://openalex.org/keywords/japan-europe-comparison","display_name":"Japan-Europe comparison","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8612868189811707},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.7805625200271606},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.673313319683075},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6589888334274292},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6168215274810791},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5835232138633728},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.4520667493343353},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4240003824234009},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36218392848968506},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3295813798904419},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.21946048736572266},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.17164522409439087},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.09867072105407715},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.06693524122238159},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0168-8278(09)60650-4","doi":"https://doi.org/10.1016/s0168-8278(09)60650-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0168-8278(09)60650-4","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2014267536","https://openalex.org/W2102284583","https://openalex.org/W4396616032","https://openalex.org/W2033469150","https://openalex.org/W2325225939","https://openalex.org/W7165160600","https://openalex.org/W2962045063","https://openalex.org/W2280550691","https://openalex.org/W2413450540","https://openalex.org/W1928458446"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2016-06-24T00:00:00"}